7 Stocks you need to know for Monday

Treatments for anemia from Amgen (AMGN | Quote | Chart | News | PowerRating) and Johnson & Johnson (JNJ | Quote | Chart | News | PowerRating) came under greater regulatory scrutiny after a German study linked the Johnson & Johnson anemia drug to increased risk of death in stroke patients.

Falling revenues due to the housing slump lead to a massive loss for the third quarter for K.B. Homes (KBH | Quote | Chart | News | PowerRating), which was actually up on the day on Friday.

JP Morgan Chase & Company (JPM | Quote | Chart | News | PowerRating) bought what was left of Washington Mutual (WM | Quote | Chart | News | PowerRating) late on Thursday as part of the biggest bank failure in U.S. history.

Walgreens (WAG | Quote | Chart | News | PowerRating) reports quarterly earnings Monday before the market opens. Analysts are expecting EPS of 0.45.

Citigroup (C | Quote | Chart | News | PowerRating) was up more than 4% late in trading on Friday, undeterred by the Wall Street bailout debate in Washington.